Skip to main navigation Skip to search Skip to main content

Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: A randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated

  • Y. M. Chen
  • , R. P. Perng
  • , Y. C. Lee
  • , J. F. Shih
  • , C. S. Lee
  • , C. M. Tsai
  • , J. Whang-Peng

Research output: Contribution to journal › Article › peer-review

55   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: A randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology